TY - JOUR
T1 - Effect of glucagon-like peptide-1 receptor agonists on major adverse cardiovascular events in patients with inflammatory bowel disease
AU - Saadeh, Michael
AU - Chandar, Apoorva Krishna
AU - Al-Kindi, Sadeer
AU - Nguyen, Vu Quang
AU - Baskin, Revital Gorodeski
AU - Katz, Jeffry
AU - Cominelli, Fabio
AU - Regueiro, Miguel
AU - Mansoor, Emad
N1 - Publisher Copyright:
© 2025 Oxford University Press. All rights reserved.
PY - 2025/7/1
Y1 - 2025/7/1
N2 - Patients with IBD are at an increased risk of major adverse cardiovascular events (MACE), potentially due to both atherosclerotic and non-atherosclerotic, inflammation- mediated pathways. In this retrospective cohort study, IBD patients with GLP-1RA use were less likely to have MACE.
AB - Patients with IBD are at an increased risk of major adverse cardiovascular events (MACE), potentially due to both atherosclerotic and non-atherosclerotic, inflammation- mediated pathways. In this retrospective cohort study, IBD patients with GLP-1RA use were less likely to have MACE.
UR - https://www.scopus.com/pages/publications/105015197934
UR - https://www.scopus.com/inward/citedby.url?scp=105015197934&partnerID=8YFLogxK
U2 - 10.1093/crocol/otaf056
DO - 10.1093/crocol/otaf056
M3 - Review article
AN - SCOPUS:105015197934
SN - 2631-827X
VL - 7
JO - Crohn's and Colitis 360
JF - Crohn's and Colitis 360
IS - 3
M1 - otaf056
ER -